Phase 3 study

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor TR Therapeutics
Registry number NCT06707103
Started 1 April 2025 Today 16 October 2026 Estimated completion 1 December 2026

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Clincial Research Site 62 Camperdown NSW Not yet recruiting
Clinical Research Site 84 Kogarah NSW Not yet recruiting
Clincial Research Site 78 Orange NSW Not yet recruiting
Clincial Research Site 85 Sydney NSW Not yet recruiting
Clincial Research Site 74 Bendigo VIC Not yet recruiting
Clincial Research Site 60 Ivanhoe VIC Recruiting
Clincial Research Site 65 Shepparton VIC Recruiting
Clincial Research Site 75 Nedlands WA Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 312

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Adults 18 years and older

* Venous insufficiency has been clinically diagnosed clinically and medically confirmed.

* Females who are neither pregnant nor breastfeeding and if of child-bearing potential are on an acceptable method of birth control.

* The Venous Ulcer should be between 2 cm2 and 12 cm2 at randomization.

* Target ulcer age must be ≥ 4 weeks at Screening.

* Participants must have adequate arterial flow as confirmed by ABI/TBI, TB, SPP, TCPo2, or Duplex Doppler.

* Body mass index (BMI) ≤ 50 kg/m2.

* HbA1C ≤12%.

Exclusion Criteria:

* Target ulcer has been treated with prohibited medications or therapies.

* History of radiation at the target ulcer site.

* Target ulcer decreases in area by 30% or more during screening period.

* History of osteomyelitis at the target ulcer within 6 months of screening.

* History of cancer in the preceding 5 years (except as noted in the protocol).

* Participants considered nutritionally deficient.

Dates on the record

Started 1 April 2025
Estimated completion 1 December 2026
Registry last updated 2 April 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 2 April 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.